「智冉医疗」完成超3亿元A轮融资，加速侵入式脑机接口临床转化

Core Viewpoint - The article discusses the recent A-round financing of Zhiruan Medical, highlighting its focus on developing next-generation technologies and conducting large-scale clinical trials [3][4]. Financing and Company Background - Zhiruan Medical has completed over 300 million yuan in A-round financing, led by various investors including social security funds and venture capital firms [3]. - Since its establishment in 2022, the company has raised nearly 500 million yuan in total financing [4]. - The company was co-founded by Dr. Fang Ying and Dr. Song Qi, both of whom have extensive backgrounds in neuroscience and AI medical technology [4]. Technology and Innovation - Zhiruan Medical specializes in invasive brain-computer interface (BCI) technology, which allows for high-resolution neural signal collection and precise neuron modulation [5]. - The company has developed proprietary high-throughput flexible electrodes that have received patent authorization in both China and the U.S., enabling efficient neural signal collection [5][6]. - A fully implanted high-throughput wireless signal acquisition system has been created, capable of collecting neural action potentials from up to 1024 channels [6]. Research and Development - The company has built a high-precision brain data platform with over 20TB of animal neural data and 6TB of human deep brain data to enhance model training and decoding performance [6]. - Zhiruan Medical has also developed a multi-degree-of-freedom implantation robot to improve the efficiency and safety of electrode implantation [6]. Industry Context - The global BCI industry is entering a rapid growth phase, with companies like Neuralink making significant advancements in human clinical trials [7]. - The shift from rigid to flexible electrodes is seen as crucial for improving signal quality and reducing immune response risks, which are key factors for clinical application [7]. - Invasive BCI technology is expected to make breakthroughs in treating conditions such as spinal cord injuries, ALS, and depression [7].